Whilst the authors acknowledge the limitations of the trial which include small numbers of self-referred patients with relatively mild IPF who had other possible causes of cough (70% had acid-reflux and 30% were on ACE-inhibitors for hypertension), this is the first, placebo-controlled trial of cough therapy in IPF. The gene discussed is ACE; the disease is Hypertension.